Torbjörn Wärnheim
board of director
Moberg Pharma
Sweden
Biography
Torbjörn Wärnheim, Director Pharmaceutical Innovation and Development. Born 1958. Has worked for the company since 2013. Prior to his position with Moberg, Torbjörn Wärnheim was Vice President R&D at Fresenius Kabi. In addition to this he has held senior level positions at ACO HUD and Pharmacia & Upjohn among others. Torbjörn Wärnheim has a broad experience of pharmaceutical development of Rx- and OTC-products, and is associate professor at Royal Institute of Technology (KTH), Stockholm, with a research background within surface chemistry and physical chemistry of lipids. Shareholding: 10 000 employee stock options (10 000 shares may be subscribed to, based on the employee stock options).
Research Interest
Medicine
